These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17517827)

  • 1. Relationship between embryonic histonic hyperacetylation and axial skeletal defects in mouse exposed to the three HDAC inhibitors apicidin, MS-275, and sodium butyrate.
    Di Renzo F; Broccia ML; Giavini E; Menegola E
    Toxicol Sci; 2007 Aug; 98(2):582-8. PubMed ID: 17517827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity.
    Di Renzo F; Cappelletti G; Broccia ML; Giavini E; Menegola E
    Toxicol Appl Pharmacol; 2007 Apr; 220(2):178-85. PubMed ID: 17320131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inhibition of embryonic histone deacetylases as the possible mechanism accounting for axial skeletal malformations induced by sodium salicylate.
    Di Renzo F; Cappelletti G; Broccia ML; Giavini E; Menegola E
    Toxicol Sci; 2008 Aug; 104(2):397-404. PubMed ID: 18483001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
    Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
    Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation.
    Camphausen K; Scott T; Sproull M; Tofilon PJ
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6066-71. PubMed ID: 15447991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VPA-related axial skeletal defects and apoptosis: a proposed event cascade.
    Di Renzo F; Broccia ML; Giavini E; Menegola E
    Reprod Toxicol; 2010 Jan; 29(1):106-12. PubMed ID: 19850124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone post-translational modifications by HPLC-ESI-MS after HT29 cell treatment with histone deacetylase inhibitors.
    Naldi M; Calonghi N; Masotti L; Parolin C; Valente S; Mai A; Andrisano V
    Proteomics; 2009 Dec; 9(24):5437-45. PubMed ID: 19834889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice.
    Shen HY; Kalda A; Yu L; Ferrara J; Zhu J; Chen JF
    Neuroscience; 2008 Dec; 157(3):644-55. PubMed ID: 18848971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axial skeletal and Hox expression domain alterations induced by retinoic acid, valproic acid, and bromoxynil during murine development.
    Kawanishi CY; Hartig P; Bobseine KL; Schmid J; Cardon M; Massenburg G; Chernoff N
    J Biochem Mol Toxicol; 2003; 17(6):346-56. PubMed ID: 14708090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
    Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
    J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone hyperacetylation during meiosis interferes with large-scale chromatin remodeling, axial chromatid condensation and sister chromatid separation in the mammalian oocyte.
    Yang F; Baumann C; Viveiros MM; De La Fuente R
    Int J Dev Biol; 2012; 56(10-12):889-99. PubMed ID: 23417411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic approaches and methods in developmental toxicology: role of HDAC inhibition in teratogenic events.
    Menegola E; Cappelletti G; Di Renzo F
    Methods Mol Biol; 2012; 889():373-83. PubMed ID: 22669677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methionine pretreatment enhances the effects of valproate on axial development in a CD1 mouse model.
    Di Renzo F; Giavini E; Menegola E
    Birth Defects Res B Dev Reprod Toxicol; 2013 Aug; 98(4):328-33. PubMed ID: 23983167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate-induced histone hyperacetylation in human and mouse cells: estimation of putative sites of histone acetylation in vivo.
    Pantazis P; Bonner WM
    J Cell Biochem; 1982; 20(3):225-35. PubMed ID: 7169496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histone deacetylase inhibitors on estradiol-induced proliferation and hyperplasia formation in the mouse uterus.
    Gunin AG; Kapitova IN; Suslonova NV
    J Endocrinol; 2005 Jun; 185(3):539-49. PubMed ID: 15930180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications in valproic acid-induced teratogenesis.
    Tung EW; Winn LM
    Toxicol Appl Pharmacol; 2010 Nov; 248(3):201-9. PubMed ID: 20705080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenic effects of sodium valproate in mice and rats at midgestation and at term.
    Menegola E; Broccia ML; Nau H; Prati M; Ricolfi R; Giavini E
    Teratog Carcinog Mutagen; 1996; 16(2):97-108. PubMed ID: 8875740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogenic activity of HDAC inhibitors.
    Giavini E; Menegola E
    Curr Pharm Des; 2014; 20(34):5438-42. PubMed ID: 24502598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.